Medico Remedies opened higher at ₹22.25, compared with its previous close of ₹22.15. During today's session, the stock has traded between ₹21.90 and ₹22.67, with an average traded price of ₹22.22. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Medico Remedies is now worth
₹ 9,298.00
resulting in a loss of
₹ 702.00 (7.02%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.35 (+1.58%)
Day High
₹22.67
Day Low
₹21.90
Day Open
₹22.25
Prev Close
₹22.15
Volume
95,928
Value Traded
₹0.21 Cr
1W Return
3.78%
1M Return
-39.27%
3M Return
-43.34%
6M Return
-41.08%
1Y Return
-55.39%
Market Cap (₹ Cr.)
187
PE Ratio
13.30
PB Ratio
2.43
Dividend Yield
-
ROE
17.38%
ROCE
26.22%
Book Value (₹)
9.10
Face Value (₹)
2.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
3.78%
6 Week
-
1 Month
-39.27%
3 Month
-43.34%
9 Month
-51.86%
No data available.
Medico Remedies closes trading window ahead of Q2FY27 results
Trading window closed from October 1, 2026. Restriction lasts until 48 hours after Q2FY27 results. Applies to insiders and designated persons per SEBI norms.
14 days agoMedico Remedies shareholders approve FY26 accounts, director reappointments
Medico Remedies held its 32nd AGM on September 22, 2026, approving all seven resolutions. Audited financial statements for FY26 adopted by requisite majority. Haresh Kapurlal Mehta reappointed as director retiring by rotation. Remuneration increases approved for Managing Director Harshit Mehta and other key personnel. Only 34 members participated in the virtual meeting out of 16,439 record date holders.
20 days agoMedico Remedies net profit rises 30% in FY26 to ₹1,311.5 crore
Net profit after tax rose 30% YoY to ₹1,311.5 crore in FY26. Revenue from operations surged 37% to ₹20,637.7 crore. Other income jumped to ₹593.4 crore driven by forex gains. 32nd AGM scheduled for September 22, 2026.
1mo agoMedico Remedies wins $1.41 million order from Dominican Republic's PROMESE/CAL
Medico Remedies has won a $1.41 million (approximately ₹13.38 crore) confirmed government supply order from PROMESE/CAL in the Dominican Republic, covering tablets, capsules, and dry syrups with a three-month execution window from August 5, 2026. This marks the company's first disclosed order win in three fiscal quarters, with FY25 revenue growth at +4.50% and profit growth at +21.70%, reflecting improving profitability on executed contracts.
2mo agoMedico Remedies pays ₹56,640 fine for non-compliance
Medico Remedies Limited settled penalties of ₹56,640 each with NSE and BSE regarding alleged non-compliance with SEBI Listing Regulations. The violation involved delayed disclosures between January 1, 2026, and February 17, 2026. The company confirmed the fines were paid on May 25, 2026, and compliance was restored effective February 18, 2026.
4mo agoMedico Remedies FY26 Net Profit Rises 30% to ₹1,311.52 Lakh
Medico Remedies Limited reported a 30% increase in FY26 net profit to ₹1,311.52 lakh, with revenue from operations growing to ₹20,637.73 lakh. For the quarter ended March 31, 2026, the company posted a net profit of ₹585.66 lakh on revenue of ₹5,680.77 lakh.
4mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Medico Remedies is now worth
₹ 9,298.00
resulting in a loss of
₹ 702.00 (7.02%)
Note: Past profits do not guarantee future returns.
